首页> 外文期刊>Journal of Radioanalytical and Nuclear Chemistry: An International Journal Dealing with All Aspects and Applications of Nuclear Chemistry >Radiolabeling and cell incorporation studies of gemcitabine HCl microspheres on bladder cancer and papilloma cell line
【24h】

Radiolabeling and cell incorporation studies of gemcitabine HCl microspheres on bladder cancer and papilloma cell line

机译:盐酸吉西他滨微球对膀胱癌和乳头状瘤细胞系的放射标记和细胞掺入研究

获取原文
获取原文并翻译 | 示例
           

摘要

In the present study incorporation differences between the developed formulations for treatment for bladder cancer was investigated by radioactive cell culture studies. Developed bioadhesive microspheres (MS) and gemcitabinehydrochloride loaded MS (GHCl-MS) were radiolabeled. After observing the optimum labeling conditions, Tc-99m-MS and Tc-99m-GHCl-MS were loaded to the chitosan gel (CG) and poloxamer gel. The in vitro cell incorporation affinity of newly developed formulations to bladder papilloma (RT4) and the carcinoma (T24) cell lines was investigated. Cell culture studies results indicate that the use of prolonged release bioadhesive CG formulation was highly improved the targeting of the GHCl to the cancer cells.
机译:在本研究中,通过放射性细胞培养研究来研究已开发的用于治疗膀胱癌的制剂之间的掺入差异。放射性标记的已开发的生物粘附微球(MS)和盐酸吉西他滨的MS(GHCl-MS)。观察最佳标记条件后,将Tc-99m-MS和Tc-99m-GHCl-MS加载到壳聚糖凝胶(CG)和泊洛沙姆凝胶上。研究了新开发的制剂对膀胱乳头状瘤(RT4)和癌细胞(T24)细胞系的体外细胞掺入亲和力。细胞培养研究结果表明,延长释放的生物粘附性CG制剂的使用大大提高了GHCl对癌细胞的靶向性。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号